Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Indian J Ophthalmol. 2018 Nov;66(11):1609-1610. doi: 10.4103/ijo.IJO_423_18.
In this new technique of cataract surgery in patients with iris-fixated phakic intraocular lens with cataract, phakic IOL is explanted at the end of surgery. Phakic IOL remains stable and securely enclaved to the iris during phacoemulsification which is performed through a small 2.2 mm incision. Endothelial protection is provided by viscodispersive OVD above the phakic IOL and space for surgery is created by high molecular weight viscocohesive OVD beneath the phakic IOL. This technique provides significant advantages from the previously described techniques in terms of chamber stability, endothelial protection, iris trauma and surgical ease.
在这项针对虹膜固定型有晶状体眼人工晶状体（phakic IOL）合并白内障患者的白内障手术新技术中，在手术结束时将摘除有晶状体眼人工晶状体。在通过 2.2mm 小切口进行的超声乳化过程中，有晶状体眼人工晶状体保持稳定并安全地固定在虹膜上。黏弹剂上方的黏弹剂（viscodispersive OVD）为内皮提供保护，而有晶状体眼人工晶状体下方的高分子量黏弹剂（viscocohesive OVD）则为手术创造空间。与之前描述的技术相比，该技术在维持前房稳定、保护内皮、减少虹膜损伤和手术便利性方面具有显著优势。
